Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
NCT06012019

Periodontitis and Inflammation: Study on Biological Samples

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-08-24

60

Participants Needed

1

Research Sites

158 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Periodontitis is a major public health problem because it is widespread in the adult population. It leads to the irreversible destruction of the anchoring tissues of the teeth, and represents a modifiable risk factor for systemic inflammatory pathologies. This chronic inflammatory disease, which is associated with oral dysbiosis involving Porphyromonas gingivalis, is triggered by a permissive immune response. It is preceded by a reversible clinical phase, during which there is no bone resorption process: gingivitis. The understanding of the key mechanisms involved in the evolution from gingivitis to periodontitis, which will allow to early identify patient at risk of periodontitis, remain unclear at this time. Neutrophils are the main cells of inflammation present within the periodontal pockets. The excess of certain neutrophils or the alteration of their functions is associated with the triggering of periodontitis, whereas their activity, finely orchestrated, would be a key to periodontal homeostasis. It is likely that some periodontal bacteria, including P. gingivalis, but also products of matrix catabolism could deregulate the physiological functions of neutrophils towards pro-inflammatory and catabolic profiles. Moreover, to date, the differentiation and role of neutrophil subsets in periodontal homeostasis as well as in gingivitis and its evolution into periodontitis remain poorly studied. The investigators hypothesize that various subsets of neutrophils may play different roles during the development of periodontitis (evolution of gingivitis to periodontitis). The primary objective is to characterize neutrophil subtypes associated with periodontal destruction during periodontitis. Secondary objectives are : 1. Identify specific interactions of tissue-activated neutrophils with the matrix microenvironment during periodontitis 2. Identify specific interactions of tissue or oral (salivary) activated neutrophils with the oral microbiota during periodontitis 3. Identify specific oral (salivary) neutrophil subtypes in periodontal health, gingivitis and periodontitis 4. Evaluate the function, including pro-osteoclastogenic function, of oral neutrophils compared to blood neutrophils stimulated by infection

CONDITIONS

Official Title

Periodontitis and Inflammation: Study on Biological Samples

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient over 18 years old
  • Affiliated to a national health insurance
  • Speaks and understands French well enough to read and understand the study information
  • Does not object to participation in the study
  • Control group: Bleeding on Probing (BOP) less than 10%, Plaque Index (PI) less than 20%, Probing Depth (PD) 3 mm or less
  • Gingivitis cases: BOP 10% or more, PD 3 mm or less
  • Periodontitis cases: BOP 10% or more, PD greater than 3 mm
Not Eligible

You will not qualify if you...

  • Received antibiotic prophylaxis, antibiotic therapy, or anti-inflammatory treatment within 3 months prior to inclusion
  • Pregnant or breastfeeding women
  • Patients with diseases causing defective neutrophil number, activity, activation, or function
  • Patients deprived of liberty by judicial or administrative decision

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Charles-Foix Hospital

Ivry-sur-Seine, France, 94200

Actively Recruiting

Loading map...

Research Team

M

Marjolaine Gosset, PU-PH

CONTACT

F

François Ferré, MCU-PH

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here